In 7/03, the Japanese manufacturers of the untainted rubella vaccine, [Kitasato Inst] met with Baxter Intl to establish a US pharmaceutical partner for import licensing/distribution of both single doses and a new MMR; they failed to reach an agreement. [August Vaccine Update/ CoG for Life]
